FR054 (b)

CAS No. 10378-06-0

FR054 (b)( (6R)-FR054 )

Catalog No. M23246 CAS No. 10378-06-0

FR054 is an inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3, with a remarkable anti-breast cancer effect.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 59 In Stock
25MG 87 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FR054 (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    FR054 is an inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3, with a remarkable anti-breast cancer effect.
  • Description
    FR054 is an inhibitor of the Hexosamine Biosynthetic Pathway (HBP) enzyme PGM3, with a remarkable anti-breast cancer effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (6R)-FR054
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis|PGM3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10378-06-0
  • Formula Weight
    329.31
  • Molecular Formula
    C14H19NO8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (303.67 mM; Need ultrasonic)
  • SMILES
    CC1=N[C@@]([C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H](COC(C)=O)O2)([H])[C@@]2([H])O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Francesca Ricciardiello, et al. Inhibition of the Hexosamine Biosynthetic Pathway by Targeting PGM3 Causes Breast Cancer Growth Arrest and Apoptosis. Cell Death Dis. 2018 Mar 7;9(3):377.
molnova catalog
related products
  • CWI1-2 HCL

    CWI1-2 HCL is an effective IGF2BP2 inhibitor, which can induce apoptosis and differentiation by binding IGF2BP2 and inhibiting its interaction with M6A-modified target transcription, and has therapeutic effects on leukemia.

  • Tubulin polymerizati...

    Tubulin polymerization-IN-43 is an inhibitor of tubulin polymerisation.

  • Juglanin

    Juglanin is a JNK activator. Juglanin with inflammation and anti-tumor activities. It can induce apoptosis and autophagy on human breast cancer cells.